Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.Title3 × 14 mg/m<sup>2</sup> Idarubicin during induction: results of a pilot study in children with AML.AuthorsCreutzig, U; Körholz, D; Niemeyer, C M; Kabisch, K; Graf, N; Reiter, A; Scheel-Walter, H; Bender-Götze, Ch; Behnisch, W; Hermann, J; Mann, G; Ritter, J; Zimmermann, MAbstractFocuses on the effect of Idarubicin (IDR) in acute myelogenous leukemia in children. Comparison between induction regimens with daunorubicin and IDR; Dose of IDR provided to children and adolescents; Toxicity after the treatment course.SubjectsACUTE myeloid leukemia in children; LEUKEMIA treatmentPublicationLeukemia (08876924), 2000, Vol 14, Issue 2, p340ISSN0887-6924Publication typeArticleDOI10.1038/sj.leu.2401670